3 results match your criteria: "St. Luke's and Roosevelt Hospitals and Columbia University[Affiliation]"
High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.
Catheter Cardiovasc Interv
January 2015
St. Luke's and Roosevelt Hospitals and Columbia University, College of Physicians and Surgeons, New York, New York; Ochsner Medical Center, New Orleans, Louisiana.
Objective: We performed a meta-analysis of randomized controlled trials of statin loading prior to percutaneous coronary intervention (PCI).
Background: Statin loading prior to PCI has been shown to decrease peri-procedural myocardial infarction (pMI) but less is known regarding the clinical benefit of pre-procedural statin loading.
Methods: We searched for trials of statin naïve patients presenting with stable angina or NSTE-ACS and treated with statins prior to PCI.
Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
J Am Coll Cardiol
April 2013
Department of Medicine, Division of Cardiology, St. Luke's and Roosevelt Hospitals and Columbia University, New York, New York, USA.
Objectives: This study evaluated differences in outcome among women and men enrolled in the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.
Background: Women and men with coronary artery disease have different clinical presentations and outcomes that might be due to differences in management.
Methods: We compared baseline variables, study interventions, and outcomes between women and men enrolled in the BARI 2D trial and randomized to aggressive medical therapy alone or aggressive medical therapy with prompt revascularization.
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial.
J Am Coll Cardiol
February 2011
Cardiology Division, St. Luke's and Roosevelt Hospitals and Columbia University, New York, New York, USA.
Objectives: The purpose of this study was to investigate the factors related to sex-specific outcomes for death and heart failure events in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) trial.
Background: In the MADIT-CRT trial, women seemed to achieve a better result from resynchronization therapy than men.
Methods: All 1,820 patients (453 female and 1,367 male) enrolled in the MADIT-CRT trial were included in this sex-specific outcome analysis that compared the effect of cardiac resynchronization therapy with defibrillator (CRT-D) relative to implanted cardioverter-defibrillator (ICD) on death or heart failure (whichever came first), heart failure only, and death at any time.